SEC62 and lung carcinoma: Thereby, 72% of all tumors showed detectable expression levels of SEC62 with the highest percentage of an increased expression compared with healthy tissue from the same origin in lung cancer (93–97%, depending on the subtype) and thyroid cancer (87–100%, depending on the subtype).